Carisoprodol use and abuse in Norway. A pharmacoepidemiological study

British Journal of Clinical Pharmacology

Volumn 64, Issue 2, 2007, Pages 210-218

  Bramness, Jørgen G ^a   Furu, Kari ^a   Engeland, Anders ^a,b   Skurtveit, Svetlana ^a,c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Carisoprodol; Meprobamate; Pharmacoepidemiology; Prescription drug abuse

Indexed keywords

BENZODIAZEPINE; CARISOPRODOL; CODEINE; DIAZEPAM; ESOMEPRAZOLE; HYPNOTIC AGENT; METFORMIN; OPIATE; SALBUTAMOL;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG ABUSE; DRUG EFFECT; DRUG MEGADOSE; DRUG TOLERANCE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NORWAY; PHARMACOEPIDEMIOLOGY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CARISOPRODOL; FEMALE; HUMANS; MALE; MEPROBAMATE; MUSCLE RELAXANTS, CENTRAL; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; SUBSTANCE-RELATED DISORDERS;

EID: 34249020960     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02847.x     Document Type: Article

References (36)

1. Berger F, Kletzkin M, Ludwig B, Margolin S. The history, chemistry, and pharmacology of carisoprodol. Ann NY Acad Sci 1960 86 : 90 107.
2. Værøy H, Abrahamsen A, Førre Ø, Kristiansen P, Kåss E. Treatment of patients with fibromyalgia: a double blind clinical trial with Somadril Comp (carisprodol, paracetamol) versus placebo. Scand J Rheumatol 1988 72 : 38S.
3. Soyka J, Maestripieri L. Soma compound (carisoprodol plus phenacetin and caffeine) in the treatment of acute, painful musculoskeletal conditions. Curr Ther Res 1979 26 : 165 80.
4. Miller AR. A comparative study of Parafon Forte tablets and Soma compound in the treatment of painful skeletal muscle conditions. Curr Ther Res Clin Exp 1976 19 : 444 50.
5. Dahl E, Grenthe B, Lindqvist B. Comparsion of changes in pain threshold following oral administration of carisoprodol, acetylsalicyclic acid, and placebo. Swed Dent J 1981 5 : 77 80.
6. Gallardo F, Molgo J, Miyazaki C, Rossi E. Carisoprodol in the treatment of myofascial pain-dysfunction syndrome. J Oral Surg 1975 33 : 655 8.
7. Waddell G, McIntosh A, Hutchinson A, Feder G, Lewis M. Low Back Pain Evidence Review, 2nd edn. London : Royal College of General Practitioners 1999.
8. van Tulder M, Waddell G. Ont I Ryggen, Ont I Nacken En Evidensbaserad Kunskapssammanställning, Stockholm : SBU 2000.
9. Raffel S, Swink R, Lampton T. The influence of chlorphenesin carbamate and carisoprodol on psychological test scores. Curr Ther Res 1969 11 : 553 60.
10. Olsen H, Koppang E, Alvan G, Mørland J. Carisoprodol elimination in humans. Ther Drug Monit 1995 16 : 337 40.
11. Rho JM, Donevan SD, Rogawski MA. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther 1997 280 : 1383 91.
12. Kamin I, Shaskan D. Death due to massive overdose of meprobamate. Am J Psychiatry 1959 115 : 1123 4.
13. Hollister LE. The pre-benzodiazepine era. J Psychoactive Drugs 1983 15 : 9 13.
14. Fraser H, Essig C, Wolbach A. Evaluation of Carisoprodol and Phenyramidol for Addictiveness. National Institute of Mental Health, Lexington: Addiction Research Centre 1961.
15. Bailey DN, Briggs JR. Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 2002 117 : 396 400.
16. Bramness JG, Skurtveit S, Grung M, Mørland J. Centrally acting muscle relaxants: abuse potential and traffic hazards. Tidsskr Nor Lægeforen 2000 120 : 1966 9.
17. Logan BK, Case GA, Gordon AM. Carisoprodol, meprobamate, and driving impairment. J Forensic Sci 2000 45 : 619 23.
18. Boothby L, Doering P, Hatton R. Carisoprodol: a marginally effective skeletal muscle relaxant with serious abuse potential. Hosp Pharmacy 2003 38 : 337 45.
19. Emergency Department Trends From the Drug Abuse Warning Network, Final estimates 1995-2002, DAWN Series D-24. Rockville, MD : SAMSHA 2003.
20. Furu K, Strøm H, Rønning M, Skurtveit S, Engeland A, Tverdal A. The Norwegain Prescription Database (NorPD): new register for pharmacoepidemiological research covering a whole nation. Pharmacoepidemiol Drug Saf 2005 14 : S48.
21. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo : WHO 2005.
22. Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratoory animals - implications for problems of long-term use and abuse. Psychopharmacology 1997 134 : 1 37.
23. Varley H, Jordan J, Bascom P. Quantities of carisoprodol (Soma (R) to be restricted. DUR Newsletter 2000.
24. APA. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision (DSM-IV-TR). Arlington : American Psychiatric Association 2000.
25. Hallas J. Drug utlization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf 2005 14 : 455 63.
26. Kampmann J. Sovemedicine og Nervemedicine - Storforbrugere. København : Lægemiddelstyrelsen 1997.
27. Isacson D, Bingefors K, Wennberg M, Dahlström M. Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Soc Sci Med 1993 36 : 343 51.
28. Reeves RR, Beddingfield JJ, Mack JE. Carisoprodol withdrawal syndrome. Pharmacotherapy 2004 24 : 1804 6.
29. Wyller T, Korsmo G, Gadeholt G. Carisoprodol-dependence. A prospective withdrawal study among prisoners. Tidsskr Nor Laegeforen 1991 111 : 193 5.
30. Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D. Lack of relationship between long term use of benzodiazepines and escalation to high dosage. Psychiatr Serv 2003 54 : 1006 11.
31. Reeves RR, Liberto V. Abuse of combinations of carisoprodol and tramadol. South Med J 2001 94 : 512 4.
32. Luo X, Pietrobon R, Curtis L, Hey L. Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States. Spine 2004 29 : E531 E7.
33. Rønning M, Harr L, Litleskare I, Sakshaug S, Ullerud T. Drug consumption in Norway, 1998-2002. Oslo : Norwegian Institute of Public Health 2003.
34. Apotekens totale försäljning av humanläkemedel 2003-2005, Apoteket AB. http://www2.apoteket.se/NR/rdonlyres/C35CF93A-7A16-4590-A414- CO8378FD1ADD/4945/2005tot.pdf (last accessed: January 2007).
35. Statistics grouped according to constituents, 2001-2005, Danish Medicines Agency. http://dkma.medstat.dk/MedStatDataViewer.php (last accessed: January 2007).
36. Reeves RR, Algood TL, Wise PM. Skeletal muscle relaxants and associated medications for nonspecific acute back pain. Pharm Ther 2005 30 : 518 24.